Sponsor Pipeline

Brainfarma Industria Química e Farmacêutica S/A Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07712913 Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With… Phase 3 Recruiting
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07626437 Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg… Common Cold/Flu Recruiting
NCT07712913 Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With… Diabetic Neuropathy Recruiting
Get alerts when Brainfarma Industria Química e Farmacêutica S/A's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free